Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Hall

Showing results (91-100 of 160) with videos related to

Pageof 16
Sort By:
BMC Public Health|November 17, 2023
Financing child rights in MalawiRachel Etter-Phoya, Chisomo Manthalu, Frank Kalizinje, et al.
Plants (Basel, Switzerland)|April 12, 2022
Characterisation of Grains and Flour Fractions from Field Grown Transgenic Oil-Accumulating Wheat Expressing Oat <i>WRI1</i>Per Snell, Mark Wilkinson, Gavin J Taylor, et al.
Clinical Therapeutics|August 4, 2010
Relationship between rheumatoid arthritis disease severity, health-related utility, and resource use in Australian patients: A cross-sectional, multicenter studyLachlan Standfield, Sarah Norris, Charles Harvey, et al.
RMD Open|July 26, 2024
Efficacy and safety of upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological treatments: results through 5 years from the SELECT-BEYOND studyRoy Fleischmann, Sebastian Meerwein, Christina Charles-Schoeman, et al.
International Journal of Rheumatic Diseases|May 17, 2023
Efficacy of certolizumab pegol across baseline rheumatoid factor subgroups in patients with rheumatoid arthritis: Post-hoc analysis of clinical trialsYoshiya Tanaka, Tsutomu Takeuchi, Derek Haaland, et al.
RMD Open|June 3, 2025
Benefit-risk analysis of upadacitinib versus adalimumab in patients with rheumatoid arthritis and higher or lower risk of cardiovascular diseaseGerd R Burmester, Eduardo Mysler, Peter Taylor, et al.
Injury|July 13, 2018
High-energy trauma patients with pelvic fractures: Management trends in Ontario, CanadaStephen M Mann, Daniel Banaszek, Katherine Lajkosz, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|January 29, 2014
Multiple risk-behavior profiles of smokers with serious mental illness and motivation for changeJudith J Prochaska, Sebastien C Fromont, Kevin Delucchi, et al.
Spine|August 30, 2014
In responseBrian J C Freeman, Guy L Ludbrook, Stephen Hall, et al.
Arthritis Care & Research|October 4, 2016
Secukinumab for Long-Term Treatment of Psoriatic Arthritis: A Two-Year Followup From a Phase III, Randomized, Double-Blind Placebo-Controlled StudyArthur Kavanaugh, Philip J Mease, Andreas M Reimold, et al.
Pageof 16

Showing results (91-100 of 160) with videos related to

Sort By:
Pageof 16
BMC Public Health|November 17, 2023
Financing child rights in MalawiRachel Etter-Phoya, Chisomo Manthalu, Frank Kalizinje, et al.
Plants (Basel, Switzerland)|April 12, 2022
Characterisation of Grains and Flour Fractions from Field Grown Transgenic Oil-Accumulating Wheat Expressing Oat <i>WRI1</i>Per Snell, Mark Wilkinson, Gavin J Taylor, et al.
Clinical Therapeutics|August 4, 2010
Relationship between rheumatoid arthritis disease severity, health-related utility, and resource use in Australian patients: A cross-sectional, multicenter studyLachlan Standfield, Sarah Norris, Charles Harvey, et al.
RMD Open|July 26, 2024
Efficacy and safety of upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological treatments: results through 5 years from the SELECT-BEYOND studyRoy Fleischmann, Sebastian Meerwein, Christina Charles-Schoeman, et al.
International Journal of Rheumatic Diseases|May 17, 2023
Efficacy of certolizumab pegol across baseline rheumatoid factor subgroups in patients with rheumatoid arthritis: Post-hoc analysis of clinical trialsYoshiya Tanaka, Tsutomu Takeuchi, Derek Haaland, et al.
RMD Open|June 3, 2025
Benefit-risk analysis of upadacitinib versus adalimumab in patients with rheumatoid arthritis and higher or lower risk of cardiovascular diseaseGerd R Burmester, Eduardo Mysler, Peter Taylor, et al.
Injury|July 13, 2018
High-energy trauma patients with pelvic fractures: Management trends in Ontario, CanadaStephen M Mann, Daniel Banaszek, Katherine Lajkosz, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|January 29, 2014
Multiple risk-behavior profiles of smokers with serious mental illness and motivation for changeJudith J Prochaska, Sebastien C Fromont, Kevin Delucchi, et al.
Spine|August 30, 2014
In responseBrian J C Freeman, Guy L Ludbrook, Stephen Hall, et al.
Arthritis Care & Research|October 4, 2016
Secukinumab for Long-Term Treatment of Psoriatic Arthritis: A Two-Year Followup From a Phase III, Randomized, Double-Blind Placebo-Controlled StudyArthur Kavanaugh, Philip J Mease, Andreas M Reimold, et al.
Pageof 16